Mulago National Specialised Hospital, also known as Mulago National Referral Hospital, is a component of Mulago Hospital Complex, the teaching facility of Makerere University College of Health Sciences. It is the largest public hospital in Uganda.

During the past decade, Mulago Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mulago Hospital" #1 sponsor was "Makerere University" with 19 trials, followed by "University of California, San Francisco" with 4 trials sponsored, "Institut National de la Santé Et de la Recherche Médicale, France" with 3 trials sponsored, "Karolinska Institutet" with 3 trials sponsored and "McMaster University" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mulago Hospital" #1 collaborator was "Makerere University" with 8 trials as a collaborator, "Mulago Hospital, Uganda" with 4 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "International Centre for Diarrhoeal Disease Research, Bangladesh" with 2 trials as a collaborator and "KEMRI-Wellcome Trust Collaborative Research Program" with 2 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Mulago Hospital" are "Tuberculosis" (7 trials), "Malaria" (3 trials), "Anemia" (2 trials), "Heart Failure" (2 trials) and "Post Operative Pain" (2 trials). Many other conditions were trialed in "Mulago Hospital" in a lesser frequency.

Most popular intervention types in "Mulago Hospital" are "Drug" (16 trials), "Other" (9 trials), "Device" (5 trials), "Procedure" (5 trials) and "Behavioral" (4 trials). Other intervention types were less common.

The name of intervention was led by "Ethambutol" (2 trials), "Isoniazid" (2 trials), "Pyrazinamide" (2 trials), "Rifampin" (2 trials) and "Sterile saline" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mulago Hospital" are 42 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Mulago Hospital". 1 are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Mulago Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mulago Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 21 trials that are defined as “Not Applicable".

Mulago Hospital has several departments that took part in Clinical trials: "Department of Paediatrics and Child Health, Mulago Hospital" - 2 trials